@article{AMJ4223,
author = {Amine Benmassaoud and Emmanuel A. Tsochatzis},
title = {The use of statins in the management of chronic liver disease},
journal = {AME Medical Journal},
volume = {3},
number = {1},
year = {2018},
keywords = {},
abstract = {Cirrhosis-related complications are a major cause of morbidity and mortality in patients with liver disease. Once decompensated cirrhosis has established itself, the patients’ median survival is less than 2 years (1). It is therefore important to prevent the development of advanced brosis, and the ensuing clinically significant portal hypertension (CSPH) (2). At the present time, very few medications have a direct impact on portal hypertension, and beta-blockers are the only ones used regularly in clinical practice.},
issn = {2520-0518}, url = {https://amj.amegroups.org/article/view/4223}
}